A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves gastrointestinal tolerability of glucagon-like peptide 1 receptor agonist therapy.
| Autor: | Knop, Filip K., Urva, Shweta, Rettiganti, Mallikarjuna, Benson, Charles T., Roell, William C., Mather, Kieren J., Haupt, Axel, Pratt, Edward, Füchtenbusch, Martin |
|---|---|
| Zdroj: | Diabetologie und Stoffwechsel; 2024 Supplement, Vol. 19, pS73-S73, 1p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|